These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21930380)

  • 1. Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors.
    Qiao Z; Wang W; Wang L; Wen D; Zhao Y; Wang Q; Meng Q; Chen G; Wu Y; Zhou H
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6389-92. PubMed ID: 21930380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of SENP1 inhibitors through in silico screening and rational drug design.
    Zhao Y; Wang Z; Zhang J; Zhou H
    Eur J Med Chem; 2016 Oct; 122():178-184. PubMed ID: 27344494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRET-based in vitro assays for the analysis of SUMO protease activities.
    Tatham MH; Hay RT
    Methods Mol Biol; 2009; 497():253-68. PubMed ID: 19107423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.
    Su L; Fang H; Yang K; Xu Y; Xu W
    Bioorg Med Chem; 2011 Jan; 19(2):900-6. PubMed ID: 21194957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family.
    Drag M; Mikolajczyk J; Krishnakumar IM; Huang Z; Salvesen GS
    Biochem J; 2008 Jan; 409(2):461-9. PubMed ID: 17916063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of Arabidopsis thaliana SUMO pathways in E. coli: functional evaluation of SUMO machinery proteins and mapping of SUMOylation sites by mass spectrometry.
    Okada S; Nagabuchi M; Takamura Y; Nakagawa T; Shinmyozu K; Nakayama J; Tanaka K
    Plant Cell Physiol; 2009 Jun; 50(6):1049-61. PubMed ID: 19376783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DeSUMOylating enzymes--SENPs.
    Drag M; Salvesen GS
    IUBMB Life; 2008 Nov; 60(11):734-42. PubMed ID: 18666185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2008 Sep; 374(2):382-7. PubMed ID: 18639523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO proteases as potential targets for cancer therapy.
    Bialik P; Woźniak K
    Postepy Hig Med Dosw (Online); 2017 Dec; 71(0):997-1004. PubMed ID: 29225200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO proteases: redox regulation and biological consequences.
    Xu Z; Chan HY; Lam WL; Lam KH; Lam LS; Ng TB; Au SW
    Antioxid Redox Signal; 2009 Jun; 11(6):1453-84. PubMed ID: 19186998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-(4-Chlorophenyl)-2-oxoethyl 4-benzamidobenzoate derivatives, a novel class of SENP1 inhibitors: Virtual screening, synthesis and biological evaluation.
    Chen Y; Wen D; Huang Z; Huang M; Luo Y; Liu B; Lu H; Wu Y; Peng Y; Zhang J
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6867-70. PubMed ID: 23044371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical Tools and Biochemical Assays for SUMO Specific Proteases (SENPs).
    Jia Y; Claessens LA; Vertegaal ACO; Ovaa H
    ACS Chem Biol; 2019 Nov; 14(11):2389-2395. PubMed ID: 31361113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression patterns of SUMO proteins in HL-60 cancer cell lines support a role for sumoylation in the development of drug resistance.
    Vigodner M; Weisburg JH; Shrivastava V; Marmor RA; Fathy J; Skop N
    Cell Tissue Res; 2009 May; 336(2):277-86. PubMed ID: 19326147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and activity of tetrapeptidic HTLV-I protease inhibitors possessing different P3-cap moieties.
    Zhang M; Nguyen JT; Kumada HO; Kimura T; Cheng M; Hayashi Y; Kiso Y
    Bioorg Med Chem; 2008 May; 16(10):5795-802. PubMed ID: 18400502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors.
    Shang L; Fang H; Zhu H; Wang X; Wang Q; Mu J; Wang B; Kishioka S; Xu W
    Bioorg Med Chem; 2009 Apr; 17(7):2775-84. PubMed ID: 19299146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a high-throughput screening assay for inhibitors of small ubiquitin-like modifier proteases.
    Yang W; Wang L; Paschen W
    J Biomol Screen; 2013 Jun; 18(5):621-8. PubMed ID: 23470489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO-specific proteases: a twist in the tail.
    Hay RT
    Trends Cell Biol; 2007 Aug; 17(8):370-6. PubMed ID: 17768054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SUMO-specific protease 1 and cancer].
    Cheng JK
    Ai Zheng; 2008 Jul; 27(7):771-4. PubMed ID: 18606075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of sumoylated proteins.
    Park-Sarge OK; Sarge KD
    Methods Mol Biol; 2009; 464():255-65. PubMed ID: 18951189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.